IP Commercialisation and Spin Out Summit 2012
27-29th February 2012
Sir Stamford Circular Quay, Sydney
Akolade’s IP Commercialisation and Spin Out Summit 2012, brings together the thought leaders and trail blazers of the Commercialisation and Spin Out landscape. Hear how successful companies have turned research and development into successful business enterprises.
Members of BioMelbourne Network are eligible for a 10% discount on attendance prices. Email Tom Action on tom.acton@akolade.com.au to find out more.
more
Molecular Approaches to Malaria Conference
Molecular Approaches to Malaria Conference. Lorne 19-23 February 2012.
more
8th February BioWorkshop - New Regulations for Biologics
8th February 2012
BioMelbourne Network | 25 Flinders Lane, Melbourne
Are you prepared for the new regulations for biologics?
more
7th February BioBreakfast: World's 1st commercial 3D bio-printer
Listed as Time Magazines 50 top inventions for 2011, the Invetech / Organovo 3D bio-printer is the first commercial bio-printer in the world capable of generating human tissues. The impact upon surgery and transplantation could be enormous.
more
GSK injects $60 million and 58 jobs at Boronia site
Minister for Technology Gordon Rich-Phillips today announced that one of the world’s leading pharmaceutical companies, GlaxoSmithKline Pty Ltd (GSK), will invest $60 million to expand its Boronia site, creating 58 new highly-skilled jobs by 2017.
more
Medicines industry tops hi-tech exporters list
New export figures published by the Australian Bureau of Statistics reveal that the Australian medicines industry was the nation's most valuable hi-tech exporter in 2011.
more
Marketing approval granted for Ellavie in Switzerland
Acrux announced today that Swissmedic, the Swiss agency for therapeutic products, has granted a marketing authorisation in Switzerland for Ellavie™, Acrux’s estradiol spray for treating menopause symptoms.
more
Immuron & Monash University to Develop a Clostridium difficile Therapeutic
Australian biopharmaceutical company Immuron Limited (ASX: IMC), manufacturer of Travelan®, has entered into a collaboration agreement with Monash University to develop a product or products that will be aimed at both prevention and treatment of Clostridium difficile (C. difficile) infections.
more
Research collaboration creates 15 new jobs for Victoria
Minister for Technology Gordon Rich-Phillips today welcomed a partnership between The Monash Institute of Pharmaceutical Sciences, Monash University (MIPS) and a leading European pharmaceutical company Les Laboratoires Servier (Servier) to undertake cutting-edge drug discovery and research activities in Victoria.
more
Evado opens US office
Evado, a clinical software provider, today announced the opening of a new office in San Francisco, California, USA. The newly appointed Director of Business Development, Ms Maria Chiam will operate from Evadoʼs US office.
more